Articles
| Open Access |
DOI: State Of Purine Exchange And Microalbuminuria In Patients With Metabolic Syndrome
Irodakhon Makhkambaevna Tashtemirova , Andijan State Medical Institute, UzbekistanAbstract
The aim of the given work was study interactions of impairments sympa-thetic – adrenal systems functional condition and processes of peroxidal oxida-tion of lipids in woman with metabolic syndrome. 107women at the age of 25-49 were observation. They were randomized into 3 groups: I (control) – 15 healthy persons, II – 43 patients with arterial hypertension, III – 49 women with arterial hypertension in combination with metabolic syndrome. The results of carried investigations showed that activation of sympathetic adrenal system and processes of peroxidal oxidation of lipids took place in metabolic syn-drome. Marked lowering of sympathetic – adrenal system key ferment catechol-amins (MAO monoaminooxidaze) desamidization activity and considerable ac-tivation of peroxidal oxidation of lipid products which have great significance in revealing the mechanism of metabolic syndrome development were observed in metabolic syndrome. This results in the prolonged toxic influence of catechola-mins on myocardium.
Keywords
Metabolic syndrome, sympathetic–adrenal system, catecholamins
References
Abilova S.S. Noruzbaeva A.M., Lunegova A.M., Mirrakhimov E.M. The value of metabolic syndrome in clinical practice. // Central Asian Medical Journal. 2004 Volume X, № 6 ,. Pp. 316-323.
Alyavi A.L., Tulyaganova D.K., Babaev M.A., Shodiev Zh.D. Dynamics of indicators of platelet homeostasis of lipid metabolism in patients with metabolic syndrome on the background of drug therapy. // Res. Scientific and practical The conference. 2018.pp. 30-31.
Balabolkin M.I., Kaminskaya V.M., Klebanova E.M. The role of endo-thelial dysfunction and oxidative stress in the mechanisms of angiopathy development in type 2 diabetes mellitus. Cardiology. 2004; 7: pp. 90-97
Dzhanashia P.Kh., Didenko V.A. Is hyperuricemia a component of the metabolic syndrome? // Ross. Cardiology journal No. 1. 2014 pp. 1-9
Donskov AS, Balkarov IM, Dadina ZM, et al. Urate kidney damage and metabolic changes in patients with arterial hypertension. Ter. archive. 2016; 6: pp 53-56.
Donskov A.S., Dadina Z.M., Golub G.V. and other Violations of purine metabolism in patients with arterial hypertension. Cardiology. 2018; 10: pp 41-47.
Kobalova Zh.D., Tolkacheva V.V., Karaulova Yu.L. Uric acid is a mark-er and / or a new risk factor for the development of cardiovascular com-plications. Rus honey zhurn. 2012; 10: pp 431-436.
Kuzaeva F.M. and others. Modern ideas about the factors causing kidney damage in gout. // Ter. archive 2005; 5: pp 90-95.
Mavlyanov I.R., Spiridonova A.Yu. Metabolic syndrome and kidney. The first Tashkent state institute , 2004, pp. 27-40.
Madyanov IV, Balabolkin MI, Grigoriev AA, Markov D; Hyperu-ricemia as a component of metabolic syndrome X. Problendocrinol. 1997; 6: from 30-32.
Mamedov M.N., Petrova N.V., Metelskaya V.A. and other Compo-nents of metabolic syndrome in patients with arterial hypertension. Car-diology. 2007; 12: pp 37-41.
Tashkenbaeva E.N. Hyperuricemia in the mechanisms of develop-ment of metabolic syndrome and cardiovascular complications. Honey. Uzbekistan Journal 2016, No. 4 pp 91-95.
Arauz-Pacheco C, Parrott M. A., Raskin P. The treatment of hyper-tension in
Bleyer A.J. et al. Renal manifest factions of a mutation in the uromodi-um (Tamm Horsfall protein) gene. Amer J kidney Dis. 2015; 42: pp20-26.
DeLeeuw, Birkenhager W.H. Kidney damage in hypertensive disease and the effects of treatment. NethJ. Med. 2015; 47: pp.199-204.
Effects of ramipril on cardiovascular and mi¬crovascular outcome's in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 2009; 355: pp 253-259.
Filer. IS Lent in resistance and obesity: Pre¬sented at the.60 th scientific ses-sions of the American diabetes association. June 13, 2000; San-Antonio, Texas.
Ford E.S., Ciles W.H., Dietr W.H. Prevalence of the metabolic syndrome amond US adults. JAMA 2012; 287: pp.356-359.
Lakka HM. Laaksonen DE. Lakka TA et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men JAMA 2018; 288: pp.2709-2716.
Malik F.S., Lavie C.J., Mehra M.R. et al. Renin-angiotensin system; Genes to bedside. Amer Heart J. 2017; 134: pp514-526.
Article Statistics
Copyright License
Copyright (c) 2021 The American Journal of Medical Sciences and Pharmaceutical Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.